Correlation Between Armata Pharmaceuticals and Pliant Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Pliant Therapeutics, you can compare the effects of market volatilities on Armata Pharmaceuticals and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Pliant Therapeutics.

Diversification Opportunities for Armata Pharmaceuticals and Pliant Therapeutics

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Armata and Pliant is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Pliant Therapeutics go up and down completely randomly.

Pair Corralation between Armata Pharmaceuticals and Pliant Therapeutics

Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 0.82 times more return on investment than Pliant Therapeutics. However, Armata Pharmaceuticals is 1.22 times less risky than Pliant Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.22 per unit of risk. If you would invest  185.00  in Armata Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of  20.00  from holding Armata Pharmaceuticals or generate 10.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Armata Pharmaceuticals  vs.  Pliant Therapeutics

 Performance 
       Timeline  
Armata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Armata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest abnormal performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Pliant Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pliant Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Armata Pharmaceuticals and Pliant Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Armata Pharmaceuticals and Pliant Therapeutics

The main advantage of trading using opposite Armata Pharmaceuticals and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.
The idea behind Armata Pharmaceuticals and Pliant Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges